Organon & Co (OGN)

Cash ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Cash and cash equivalents US$ in thousands 675,000 763,000 704,000 575,000 693,000 414,000 326,000 459,000 706,000 499,000 545,000 694,000 737,000 1,008,000 730,000 141,000 500,000
Short-term investments US$ in thousands -762,237
Total current liabilities US$ in thousands 2,718,000 2,790,000 2,755,000 2,545,000 2,918,000 2,491,000 2,387,000 2,346,000 2,512,000 2,328,000 2,396,000 2,306,000 2,597,000 3,129,000 2,975,000 2,875,000 1,201,000
Cash ratio 0.25 0.00 0.26 0.23 0.24 0.17 0.14 0.20 0.28 0.21 0.23 0.30 0.28 0.32 0.25 0.05 0.42

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($675,000K + $—K) ÷ $2,718,000K
= 0.25

The cash ratio of Organon & Co has shown some fluctuations over the observed period, ranging from a low of 0.00 to a high of 0.42. The cash ratio measures the company's ability to cover its short-term liabilities with its cash and cash equivalents. A higher ratio indicates that the company has a greater ability to meet its short-term obligations using its readily available cash, while a lower ratio may suggest liquidity concerns.

Looking at the trend over the period, there are noticeable fluctuations in the cash ratio. The ratio decreased sharply from 0.42 on December 31, 2020, to 0.05 on March 31, 2021, indicating a significant decrease in the company's ability to cover its short-term liabilities with cash during that period. Subsequently, there were fluctuations in the ratio, with some periods showing improvements and others showing declines.

Organon & Co's cash ratio seems to have stabilized around the range of 0.20 to 0.30 in the later periods, although it dropped to 0.00 on September 30, 2024, which could be a point of concern as it indicates a lack of cash to cover short-term obligations.

Overall, it would be essential for Organon & Co to monitor its cash position closely and ensure that it maintains a healthy cash ratio to meet its short-term financial commitments effectively.